Trademarkia Logo

Australia

AU$
Trademark Search
EnfiniT platform for CAR-T
EnfiniT platform for CAR-T
Cancelled: Cancelled at the request of IB

Last updated on 8 Mar 2023

Owner Info

MNEMO THERAPEUTICS

7-11 boulevard Haussmann

F-75009 Paris, FRANCE

Serial Number

2240890 filed on 14 Sept 2021

Correspondent

Gide Loyrette Nouel AARPI, Madame Raphaëlle Dequiré-Portier

15 rue de Laborde,

F-75008 PARIS,

FRANCE

EnfiniT platform for CAR-T

Classification Information


Class [001]
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunothera Read More

Class [005]
Pharmaceutical products; biological and pharmaceutical preparations; biological and pharmaceutical preparations for treating cancer and tumors using i Read More

Class [040]
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacturing antigens, antibodies, T-cells.

Class [042]
Scientific research services for medical purposes; identifying, screening and developing antigens; scientific and technological services; scientific l Read More

Class [044]
Providing medical information in the field of manufacturing pharmaceuticals; providing medical information relating to immunotherapy.

Mark Details


Serial Number

2240890

Registered On

14 Sept 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

26 May 2021

Mark Type

FR

Legal History


Show more

Status DateAction Taken
8th Mar 2023IP Right Goods and Services Items updated
8th Mar 2023IP right goods and service classes updated
6th Mar 2023Status change to Voided
2th Mar 2023International Registration - Correction Received
2th Jun 2022International Registration in Australia Protected After Adverse (No amendments) correspondence sent
1st Jun 2022International Registration in Australia Protected After Adverse (No amendments) correspondence sent
1st Jun 2022IP Right Registration Published
1st Jun 2022Status change to Registered/Protected
25th Mar 2022Application Accepted correspondence sent
24th Mar 2022Application Accepted correspondence sent